Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: effects on food-reinforced behavior and comparisons with AM4113.
about
The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in ratsPotential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142.2012 Division of medicinal chemistry award address. Trekking the cannabinoid road: a personal perspectiveThe novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behaviorCentral mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in ratsReceptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists.Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats.Therapeutic modulation of cannabinoid lipid signaling: metabolic profiling of a novel antinociceptive cannabinoid-2 receptor agonistEffects of opioids, cannabinoids, and vanilloids on body temperature.Translational strategies for therapeutic development in nicotine addiction: rethinking the conventional bench to bedside approach.Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders.The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.CB1 antagonism produces behaviors more consistent with satiety than reduced reward value in food-maintained responding in ratsInverse agonism of cannabinoid CB1 receptors potentiates LiCl-induced nausea in the conditioned gaping model in rats.Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel MonkeysEvaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats.Addition of a low dose of rimonabant to orlistat therapy decreases weight gain and reduces adiposity in dietary obese rats.Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk.Differential effects of cannabinoid CB1 inverse agonists and antagonists on impulsivity in male Sprague Dawley rats: identification of a possibly clinically relevant vulnerability involving the serotonin 5HT1A receptor.Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats.
P2860
Q30355922-183EA3AF-ECF4-4218-A866-1D0368FFAA92Q33635704-F82B2AB1-49B9-4FCE-B26B-15DC145B2623Q33781776-3271A939-40C1-459B-AB1A-1B1E53E36EB6Q34131412-479C8C50-32D4-41E0-A62E-6B3C7338EB5DQ34168253-5020445A-F894-4A96-A98B-AD102F5B44A6Q34453695-5F32715A-6985-477B-AA43-EC0C797B0805Q35586638-C6B858D8-DF75-499C-B537-1767CF15F61CQ36385052-FAC2411B-A691-4DBF-81E3-B63184C99DE5Q37692352-F5080B8B-CA0A-4FC0-A354-C3954411DA0FQ37728629-B019D32C-4B52-4698-B134-E890E621478DQ38025166-FB81F3C0-B2FA-4355-A883-FEC9F4CF6C86Q40446321-9F4E238F-FC3C-47BB-8567-018C823317D5Q41155245-960E790F-76F4-4622-AED2-74314AA36CC3Q41682319-F4FBBD28-05ED-4E45-B585-ABE826BC01CAQ41873288-351B0753-3011-41B3-A6AB-B63DC71FC10CQ41907106-921FEB94-0270-474C-809A-921E45D47A61Q44066771-E8AF860E-5D66-49E3-86C4-969832A0CCE0Q45288843-DD87DD74-72E9-4114-9D48-FA151631AFABQ45300313-A731DEF0-C11D-4F15-A646-6B28DCD67988Q52842340-EAD44C2A-79C4-4281-95E4-225549097EDA
P2860
Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: effects on food-reinforced behavior and comparisons with AM4113.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Oral bioavailability of the no ...... r and comparisons with AM4113.
@en
Oral bioavailability of the no ...... r and comparisons with AM4113.
@nl
type
label
Oral bioavailability of the no ...... r and comparisons with AM4113.
@en
Oral bioavailability of the no ...... r and comparisons with AM4113.
@nl
prefLabel
Oral bioavailability of the no ...... r and comparisons with AM4113.
@en
Oral bioavailability of the no ...... r and comparisons with AM4113.
@nl
P2093
P2860
P1476
Oral bioavailability of the no ...... r and comparisons with AM4113.
@en
P2093
P2860
P304
P356
10.1016/J.PBB.2008.07.013
P407
P577
2008-07-24T00:00:00Z